Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)
- Resource Type
- Article
- Authors
- Zhao, Hongyun; Yao, Wenxiu; Min, Xuhong; Gu, Kangsheng; Yu, Guohua; Zhang, Zhonghan; Cui, Jiuwei; Miao, Liyun; Zhang, Li; Yuan, Xia; Fang, Yong; Fu, Xiuhua; Hu, Chengping; Zhu, Xiaoli; Fan, Yun; Yu, Qitao; Wu, Gang; Jiang, Ou; Du, Xiuping; Liu, Jiwei; Gu, Wei; Hou, Zhiguo; Wang, Quanren; Zheng, Rongrong; Zhou, Xianfeng
- Source
- In Journal of Thoracic Oncology September 2021 16(9):1533-1546
- Subject
- Language
- ISSN
- 1556-0864